NeoGenomics Laboratories, Inc., a leading provider of cancer-focused genetic testing services, is headquartered in the United States. Founded in 2001, the company has established itself as a key player in the oncology diagnostics industry, with major operational regions across North America and Europe. Specialising in a comprehensive range of services, including molecular testing, pathology, and clinical trial support, NeoGenomics is renowned for its innovative approach to cancer diagnostics. The company’s commitment to high-quality, accurate testing has positioned it as a trusted partner for healthcare providers and researchers alike. With numerous accolades and a robust market presence, NeoGenomics continues to advance the field of oncology through cutting-edge technology and a dedication to improving patient outcomes.
We don't have data for NeoGenomics Laboratories, Inc., but we can show you information about their parent organization instead.
View parent company